Sentences with phrase «grant funded programs»

She has experience in supervising grant funded programs as well as research.

Utilized techniques such as cold calling, job fair attendance, fieldwork, networking, and web searches to develop employment leads for participants enrolled in various Goodwill grant funded programs.

Executive Project / Program / Healthcare Manager offering 15 + years of experience in managing implementation of healthcare insurance applications, electronic healthcare records applications, health information systems, revenue cycle management, healthcare facilities and grant funded programs grant writing, budget management, operational improvement and project management.

ACS also sterilizes pets for the Community Cat Program, and numerous grant funded programs.

You can find a description of the grant funded programs here.

The Wellness and Prevention Office includes the MPS Health and PE departments, MPS Ropes and Challenge Course, Safe and Drug - Free Schools, and other grant funded programs.

To help you through the maze, ScienceCareers details some of the grant funding programs in the decision sciences.

During her time at the National Science Foundation, Kearney managed a range of grant funding programs related to biodiversity and evolutionary biology, among other topics.

to provide grant funded programming for gay men in Denver and Colorado Springs.

Through the Long Island Regional Special Education Technical Assistance Support Center (LI RSE - TASC), a State Education department grant funded program, a dedicated initiative is being implemented to support student and teacher self - determination.

For authorizers and agencies who are interested in getting support for their work to authorize quality school restarts, consider submitting an application to participate in the grant funded program, Kickstart School Restart.

This site offers information on the free clinic grant funding program administered by the Michigan Department of Health and Human Services.

Creates Power Point presentations... quarterly reports for grant funded program.

Not exact matches

The Individual Development Account (IDA) matched savings grant program offers qualified participants an opportunity to use their funds for a variety of business purchases including the expenses of attending and participating in a trade show.

When customers buy (PRODUCT) RED products, Apple donates a portion of the proceeds to the Global Fund HIV / AIDS grants that provide a range of programs to eradicate AIDS or help people who have been affected by AIDS.

Facade improvements were funded through a matching grant program to encourage commercial development in Albany.

In addition to the fund, Stanford provided a $ 3.6 million grant to the accelerator program to be doled out over three years.

With the grant funding, individual policeman will be embedded in the community doing social work — everything from youth programs to beautifying the area.

The Bush Administration had proposed to zero it out and roll it into the Community Development Block Grants, and then cut the consolidated program's funding.

Funded with a $ 1.6 million grant from Google, the online program enables smaller amounts of food to be rescued that might otherwise go to waste.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

MINISTER for Women's Interests Rhonda Parker has recently announced 21 projects to receive funding through round three of the Centenary of Women's Suffrage grants program.

The 14 - person company has raised a total of $ 3.4 million in seed and Series A financing, as well as received a $ 2 million grant from the Department of Energy's SunShot Incubator Program, which funds up to $ 12 million in grant money to small businesses and entrepreneurs working on both hardware and software technology that makes solar more accessible for Americans.

The budget also proposes block granting Medicaid and the Children's Health Insurance Program (CHIP) at pre-ACA levels along with a state option of per - capita cap funding.

Those planning to start up «the right business» will have a much easier time finding government grant programs that may provide the needed funds.

Instead, they agreed to a symbolic payment of $ 1 each and asked the city to fund $ 200,000 for a grant program for high school students aspiring to become entrepreneurs.

However, the downside is that you can only have your mortgage funded through Quontic if you want to take advantage of the grant match program.

The program is being funded by a $ 100,000 grant from the W.K. Kellogg Foundation.

The initial $ 220 million investment in the fiber optic system was funded, in part, by a $ 111.6 million federal grant provided as part of the federal stimulus program in 2010 designed to spur jobs and the development of a smarter electric grid.

The grants will fund innovative programs that improve urban water quality, enhance storm water management and protect and restore urban waterways.

In addition to pledging a total of $ 3 million in grant funding to recovery and relief efforts to assist pets and pet owners in need, the company's PetSmart Charities philanthropic arm coordinated deliveries of several truckloads of critically needed pet food and pet supplies as part of its Buy A Bag, Give A Meal program to communities deeply impacted by the hurricanes.

Rockwell Collins» Green Communities program passes $ 1 million mark in total donations - Apr 19, 2018 - Rockwell Collins has announced the recipients of this year's Green Communities grants, a program that helps fund environmental projects in communities that Rockwell Collins operates in.

The Council manages a research funding initiative called the Matching Grants Research Program, which has invested more than $ 65 million to create a broader economic impact that has been projected to exceed $ 1 billion.

Under most programs, as long as you own and occupy your home for a certain period of time, you do not have to repay grant funds.

Lots of woman take advantage of the programs, some funding is in the form of a grant (free money!)

Typically, this venture may have small amounts of funding through grants, university programs or competitions but has not taken any significant private investment.

«They're planning on funding this Canada Job Grant on the backs of our most vulnerable workers,» said Duguid, adding that the program would leave Ontario on the hook for $ 232 million.

The provincial and federal governments provide more than $ 3 billion in funding and support to Canada's agriculture and agri - food sector through a variety of grant and loan programs offered through Growing Forward 2 (GF2).

With the help of World Relief's federal Matching Grant program, he was able to fund his CNA certification and find a job that would accommodate his school schedule while covering the families living expenses.

The bill applies only to colleges that receive state funding — but that includes state grants and loans to students, most importantly under the «Cal Grant» program that assists academically promising students from modest - income families.

Created Race to the Top: With funds from stimulus, started $ 4.35 billion program of competîtive grants to encourage and reward states for education reform.

Federal funds are also granted to state public health programs ($ 66,000,000 in the fiscal year 1969) Community mental health receives a minimum of 15 percent of each state's allotment, and 70 percent of the grant is available to support services in communities for which both public and private nonprofit groups may apply.

In addition, USDA helps organic stakeholders access programs that support conservation, provide access to loans and grants, fund organic research and education, and mitigate threats from pests and diseases.

Additional efforts to further the mission of Simply Organic are funded by an annual grant program called the Simply Organic Giving Fund that supports training and community projects for organic farmers where our spices are grown, as well as a variety of organizations and events that study, support and promote organic agriculture.

Voiceless has worked to address this problem, by supporting the establishment of THINKK, and by providing funding to a number of kangaroo related projects through its annual grants program.

Wind, Solar, Efficiency Grants Awarded to Farmers U.S. Agriculture Secretary Vilsack has announced that 424 projects across the country will receive funding for energy efficiency and renewable energy system investments through the Rural Energy for America Program (REAP)...

The three projects are being supported with $ 1,275,000 from USDA's Specialty Crop Block Grant Program, along with matching funds from recipients.

To support the Sustainable Winegrowing Program, the U.S. Department of Agriculture's Natural Resources Conservation Service has awarded a $ 475,000 matching fund grant for the development of air and water quality innovations.

The Hershey Company received funding to the tune of $ 2.5 m from the Opportunity Grant Program in 2010 as an aid to the modernisation project.

The project has received funding from the European Union's Horizon 2020 research and innovation program, under grant agreement No. 688338.